Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
NSCLC
.
Show all posts
Showing posts with label
NSCLC
.
Show all posts
Wednesday, August 5, 2026
Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-Positive NSCLC
›
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically pr...
Thursday, August 8, 2013
Phase III trial shows afatinib offers clinical benefit to patients with EGFR mutation positive NSCLC
›
We know that, Afatinib ( INN ; trade name Gilotrif , previously Tomtovok and Tovok ) is an approved drug against non-small ...
Thursday, October 18, 2012
Synta announces results from ganetespib Phase 2b trial on NSCLC
›
In continuation of my update on Ganetespib .... "The preliminary results from GALAXY indicate that the addition of ganetespib t...
›
Home
View web version
